Class II HDACs mediate CaMK-dependent signaling to NRSF in ventricular myocytes

Journal of Molecular and Cellular Cardiology

Volumn 41, Issue 6, 2006, Pages 1010-1022

  Nakagawa, Yasuaki ^a   Kuwahara, Koichiro ^a   Harada, Masaki ^a   Takahashi, Nobuki ^a   Yasuno, Shinji ^a   Adachi, Yuichiro ^a   Kawakami, Rika ^a   Nakanishi, Michio ^a   Tanimoto, Keiji ^a   Usami, Satoru ^a   Kinoshita, Hideyuki ^a   Saito, Yoshihiko ^a   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Ca calmodulin kinase; Endothelin; HDAC; Natriuretic peptide; NRSF

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; ENDOTHELIN 1; HISTONE DEACETYLASE 2; NEURON RESTRICTIVE SILENCER FACTOR; PROTEIN; PROTEIN KINASE (CALCIUM,CALMODULIN); UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART VENTRICLE; MALE; MOUSE; MUTATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BASE SEQUENCE; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARDIOMEGALY; DISEASE MODELS, ANIMAL; DNA PROBES; ENDOTHELIN-1; HISTONE DEACETYLASES; HUMANS; MICE; MUTATION; MYOCYTES, CARDIAC; RATS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

ADENOVIRIDAE;

EID: 33751349707     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.08.010     Document Type: Article

References (49)

1. Chien K.R., Knowlton K.U., Zhu H., and Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J. 5 (1991) 3037-3046
2. Sen L., and Smith T.W. T-type Ca2+ channel are abnormal in genetically determined cardiomyopathic hamster hearts. Circ. Res. 75 (1994) 149-155
3. Hasebe N., Hittinger L., Kohin S., Shen Y.T., Graham R.M., and Vatner S.F. Effect of hypertrophy on left atrial and ventricular compliance and plasma ANF levels in conscious dogs. Am. J. Physiol. 268 (1995) H781-H787
4. Tsutamoto T., Wada A., Maeda K., Hisanaga T., Maeda Y., Fukai D., et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure. Circulation 96 (1997) 509-516
5. Gottlieb S.S., Kukin M.C., Ahern D., and Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J. Am. Coll. Cardiol. 13 (1989) 1534-1539
6. Yasue H., Yoshimura M., Sumida H., Kikuta K., Kugiyama K., Mukoyama M., et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90 (1994) 195-203
7. Nishikimi T., Yoshihara F., Morimoto A., Ishikawa K., Ishimitsu T., Saito Y., et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 28 (1996) 22-30
8. Kraner S.D., Chong J.A., Tsay H.J., and Mandel G. Silencing the type II sodium channel gene; a model for neural-specific gene regulation. Neuron 9 (1992) 37-44
9. Mori N., Schoenherr C., Vandenvergh D.J., and Anderson D.J. A common silencer element in the SCG10 and type II Na+ channel genes binds a factor present in nonneuronal cells but not in neuronal cells. Neuron 9 (1992) 45-54
10. Chong J.A., Tapia-Ramirez J., Kim S., Tolendo-Arai J.J., Zheng Y., Boutros M.C., et al. REST; a mammalian silencer protein that restricts sodium channel gene expression to neurons. Cell 80 (1995) 949-957
11. Schoenherr C.J., and Anderson D.J. The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes. Science 267 (1995) 1360-1363
12. Kuwahara K., Saito Y., Ogawa E., Nobuki T., Nakagawa Y., Naruse Y., et al. The neuron-restrictive silencer element-neuron-restrictive silencer factor system regulates basal and Endothelin-1-inducible atrial natriuretic peptide gene expression in ventricular myocytes. Mol. Cell. Biol. 21 (2001) 2085-2097
13. Ogawa E., Saito Y., Kuwahara K., Harada M., Miyamoto Y., Hamanaka I., et al. Fibronectin signaling stimulates BNP gene transcription by inhibiting neuron-restrictive silencer element-dependent repression. Cardiovasc. Res. 53 (2002) 451-459
14. Kuwahara K., Saito Y., Takano M., Arai Y., Yasuno S., Nakagawa Y., et al. NRSF regulate the fetal cardiac gene program and maintains normal cardiac structure and function. EMBO J. 22 (2003) 6310-6321
15. Grozinger C.M., and Schreiber S.L. Deacetylase enzymes. Biological functions and the use of small-molecule inhibitors. Chem. Biol. 9 (2002) 3-16
16. Gray S.G., and Ekstrom T.J. Review the human hidtone deacetylase family. Exp. Cell Res. 262 (2001) 75-83
17. Lu J., McKinsey T.A., Nicol R.L., and Olson E.N. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc. Natl. Acad Sci. U. S. A. 97 (2000) 4070-4075
18. McKinsey T.A., Zhang C.L., and Olson E.N. Identification of a signal-responsive nuclear export sequence in class II histone deacetylase. Mol. Cell. Biol. 21 (2001) 6312-6321
19. McKinsey T.A., Zhang C.L., and Olson E.N. Signal-dependent nuclear export of a histone deactylase regulates muscle differentiation. Nature 408 (2000) 106-111
20. Zhang C.L., McKinsey T.A., Chang S., Antos C.L., Hill J.A., and Olson E.N. Class II histone deacetylases act as signal responsive repressors of cardiac hypertrophy. Cell 110 (2002) 479-488
21. Jin Y.H., Jeon E.J., Li Q.L., Lee Y.H., Choi J.K., Kim W.J., et al. Transforming growth factor-b stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation. J. Biol. Chem. 279 (2004) 29409-29417
22. Vega R.B., Matsuda K., Oh J., Barbosa A.C., Yang X., Meadows E., et al. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119 (2004) 555-566
23. Wang A.H., Gregoire S., Zika E., Xial L., Li C.S., Li H., et al. Identification of the ankyrin repeat proteins ANKRA and RFXANK as novel partners of class IIa histone deacetylases. J. Biol. Chem. 280 (2005) 29117-29127
24. Kanegae Y., Makimura M., and Saito I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn. J. Med. Sci. Biol. 47 (1994) 157-166
25. Nakagawa O., Ogawa Y., Itoh H., Suga S., Komatsu Y., Kishimoto I., et al. Rapid transcriptional activation and early m RNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptides as an emergency cardiac hormone against ventricular overload. J. Clin. Invest. 96 (1995) 1280-1287
26. Knowltone K.U., Rockman H.A., Itami M., Vovan A., Seidman C.E., and Chien K.R. Divergent pathways mediate the induction of ANF transgenes in neonatal and hypertrophic ventricular myocardium. J. Clin. Invest. 96 (1995) 1311-1318
27. Izumi T., Saito Y., Kishimoto I., Harada M., Kuwahara K., Hamanaka I., et al. Blockade of the natriuretic peptide receptor guanylyl cyclase-A inhibits NF-kappaB activation and alleviates myocardial ischemia/reperfusion injury. J. Clin. Invest. 108 (2001) 203-213
28. Harada K., Komuro I., Zou Y., Kudoh S., Kijima K., Matsubara H., et al. Acute pressure overload could induce hypertrophic response in the heart of angiotensin II type 1a knockout mice. Circ. Res. 82 (1998) 779-785
29. Saito Y., Nakao K., Mukoyama M., Shirakami G., Ito H., Yamada T., et al. Application of monoclonal antibodies for endothelin to hypertensive research. Hypertension 15 (1990) 734-738
30. Nakao K., Ogawa Y., Suga S., and Imura H. Molecular biology and biochemistry of the natriuretic peptide system, I: natriuretic peptides. J. Hypertens. 10 (1992) 907-912
31. Naruse Y., Aoki T., Kojima T., and Mori M. Neural restrictive silencer factor recruits mSin3 and histone deacetylase complex to repress neuron-specific target genes. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 13691-13696
32. Roopra A., Aharling L., Wood I., Briggs E., Bachfischer U., Paquette J.A., et al. Transcriptional repression by neuron-restrictive silencer factor is mediated via the sin3-histone deacetylase complex. Mol. Cell. Biol. 20 (2000) 2147-2157
33. Kao H.Y., Downes M., Ordentlich P., and Evans R.M. Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression. Genes Dev. 14 (2000) 55-56
34. Irons C.E., Sei C.A., Hidaka H., and Glembotski C.C. Protein kinase C and calmodulin kinase are required for Endothelin-stimulated atrial natriuretic factor secretion from primary atrial myocyte. J. Biol. Chem. 267 (1992) 5211-5216
35. Chen Z.F., Paquette A.J., and Anderson D.J. NRSF/REST in required in vivo for repression of multiple neuronal target genes during embryogenesis. Nat. Genet. 20 (1998) 136-142
36. Colomer J.M., Mao L., Rockman H.A., and Means A.R. Pressure overload selectively up-regulates Ca2+/calmodulin-dependent protein kinase II in vivo. Mol. Endocrinol. 17 2 (2003) 183-192
37. Saito T., Fukuzawa J., Osaki J., Sakuragi H., Yao N., Haneda T., et al. Roles of calcineurin and calcium/calmodulin-dependent protein kinase II in pressure overload-induced cardiac hypertrophy. J. Mol. Cell. Cardiol. 35 (2003) 1153-1160
38. Andres M.E., Burger C., Peral-Rubio M.J., Battaglioli E., Anderson M.E., Grimes J., et al. CoREST: a functional corepressor required for regulation of neural-specific gene expression. Proc. Natl. Acad Sci. U. S. A. 96 (1999) 9873-9878
39. Verdin E., Dequiedt F., and Kasler H.G. Class II histone deacetylases: versatile regulators. Trends Genet. 19 (2003) 286-293
40. Zhang T., and Brow J.H. Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure. Cardiovasc. Res. 63 (2004) 476-486
41. Cornelius T., Holmer S., Muller F., Riegger G., and Schunkert H. Regulation of the rat atrial natriuretic peptide gene after acute imposition of left ventricular pressure overload. Hypertension 30 (1997) 1348-1355
42. Harsdorf R.V., Edwards J.G., Shen Y.T., Kudej R.K., Diets R., Leinwand L.A., et al. Identification of a cis-acting regulatory element conferring induciblity of the atrial natriuretic factor gene in acute pressure overload. J. Clin. Invest. 100 (1997) 1294-1304
43. Sprenkle A.B., Murray S.F., and Glembotski C.C. Involvement of multiple cis elements in basal- and alpha-adrenergic agonist-inducible atrial natriuretic factor transcription. Circ. Res. 77 (1995) 1060-1069
44. Backs J., Song K., Chang S., and Olson E.N. CaM kinase II induces cardiomyocyte hypertrophy through a site-specific interaction with histone deacetylase 4. Circulation 112 (2005) 2-37
45. Black B.L., and Olson E.N. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol. 14 (1998) 167-196
46. Miska E.A., Karlsson C., Langley E., Nielsen S.J., Pines J., and Kouzarides T. HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J. 18 (1999) 5099-5107
47. Morin S., Charron F., Robitaille L., and Nemer M. GATA-dependent recruitment of MEF2 proteins to target promoters. EMBO J. 19 (2000) 2046-2055
48. Durocher D., Chen C.Y., Ardati A., Schwarz R.J., and Nemer M. The ANF promoter is a downstream target for Nkx-2.5 in the myocardium. Mol. Cell. Biol. 16 (1996) 4648-4655
49. Durocher D., Charron F., Warren R., Schwarz R.J., and Nemer M. The cardiac transcription factors Nkx-2.5 and GATA-4 are mutual cofactors. EMBO J. 16 (1997) 5658-5696